Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Scheifele

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
The Pediatric Infectious Disease Journal|June 1, 2012
The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008Ben Tan, Julie Bettinger, Athena McConnell, et al.
Vaccine|May 15, 2003
Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccineScott A Halperin, David Scheifele, Elaine Mills, et al.
Vaccine|April 6, 2010
Regrettable lack of definition of the "well tolerated" vaccineDavid Scheifele, Scott Halperin, Danuta Skowronski, et al.
Pediatrics|November 5, 2003
Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACTNicole Le Saux, Nicholas J Barrowman, Dorothy L Moore, et al.
The Pediatric Infectious Disease Journal|July 19, 2014
A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of ageFranck Thollot, David Scheifele, Heidemarie Pankow-Culot, et al.
The Pediatric Infectious Disease Journal|May 7, 2008
Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, CanadaJames D Kellner, David Scheifele, Otto G Vanderkooi, et al.
Vaccine|May 12, 2009
Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of ageScott A Halperin, Giuseppe Ferrera, David Scheifele, et al.
Pediatrics|December 5, 2003
Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impactDanuta M Skowronski, Valencia P Remple, Jane Macnabb, et al.
Vaccine|August 5, 2017
Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasonsConstantina Boikos, Lawrence Joseph, David Scheifele, et al.
Human Vaccines & Immunotherapeutics|March 9, 2017
Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosisConstantina Boikos, Jesse Papenburg, Christine Martineau, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
The Pediatric Infectious Disease Journal|June 1, 2012
The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008Ben Tan, Julie Bettinger, Athena McConnell, et al.
Vaccine|May 15, 2003
Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccineScott A Halperin, David Scheifele, Elaine Mills, et al.
Vaccine|April 6, 2010
Regrettable lack of definition of the "well tolerated" vaccineDavid Scheifele, Scott Halperin, Danuta Skowronski, et al.
Pediatrics|November 5, 2003
Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACTNicole Le Saux, Nicholas J Barrowman, Dorothy L Moore, et al.
The Pediatric Infectious Disease Journal|July 19, 2014
A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of ageFranck Thollot, David Scheifele, Heidemarie Pankow-Culot, et al.
The Pediatric Infectious Disease Journal|May 7, 2008
Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, CanadaJames D Kellner, David Scheifele, Otto G Vanderkooi, et al.
Vaccine|May 12, 2009
Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of ageScott A Halperin, Giuseppe Ferrera, David Scheifele, et al.
Pediatrics|December 5, 2003
Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impactDanuta M Skowronski, Valencia P Remple, Jane Macnabb, et al.
Vaccine|August 5, 2017
Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasonsConstantina Boikos, Lawrence Joseph, David Scheifele, et al.
Human Vaccines & Immunotherapeutics|March 9, 2017
Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosisConstantina Boikos, Jesse Papenburg, Christine Martineau, et al.
Pageof 5